DYNAMICS OF LIVER FIBROSIS MARKERS AND INSULIN RESISTANCE DURING TREATMENT WITH SODIUM–GLUCOSE COTRANSPORTER 2 (SGLT-2) INHIBITORS

Najmutdinova Dilorom Qamardinovna, Ismoilova Shaxnoza Samandarovna

Klinik fanlar yilnomasi · 2025-yil

Annotatsiya

This study evaluated the effect of SGLT-2 inhibitors on liver fibrosis indices (Fib-4, NAFLD fibrosis score) and insulin resistance (HOMA-IR) in patients with type 2 diabetes, as well as the correlation between these variables. The results demonstrated a statistically significant decrease in Fib-4 and NFS values following therapy, along with a strong positive correlation between fibrosis indices and HOMA-IR (ρ >0.85; p < 0.001). These findings support the hepatoprotective and metabolic effects of SGLT-2 inhibitors.

Maqola ma’lumotlari
MualliflarNajmutdinova Dilorom Qamardinovna, Ismoilova Shaxnoza Samandarovna
JurnalKlinik fanlar yilnomasi
Nashr sanasi2025-10-30
Jild2
Son3/1
TilO‘zbek

Kalit so‘zlar

Type 2 diabetes mellitus, MAYJK, SGLT-2 inhibitors, Fib-4, liver fibrosis, NAFLD fibrosis score, insulin resistancy, сахарный диабет 2 типа, МАЖБП, ингибиторы SGLT-2, индекс Fib-4, фиброз печени, индекс фиброза, инсулинорезистентность, 2-tip qandli diabet, MAYJK, SGLT-2 ingibitorlari, Fib-4, jigar fibrozi, NAFLD fibroz indeksi, insulin rezistentlik

Ilmiy soha

Klinik fanlar yilnomasi jurnalidan boshqa maqolalar

Klinik fanlar yilnomasi — barcha maqolalar